PlainRecalls
FDA Drug Low Class III Terminated

Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tablets), Rx Only, Distributed by Wyeth Pharmaceuticals LLC A subsidiary of Pfizer In Philadelphia, PA 19101 Made in Ireland, NDC 00008-1123-12

Reported: July 1, 2020 Initiated: May 27, 2020 #D-1342-2020

Product Description

Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tablets), Rx Only, Distributed by Wyeth Pharmaceuticals LLC A subsidiary of Pfizer In Philadelphia, PA 19101 Made in Ireland, NDC 00008-1123-12

Reason for Recall

Failed Dissolution Specifications

Details

Recalling Firm
Pfizer Inc.
Units Affected
544400 packages
Distribution
Nationwide within the United States
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tablets), Rx Only, Distributed by Wyeth Pharmaceuticals LLC A subsidiary of Pfizer In Philadelphia, PA 19101 Made in Ireland, NDC 00008-1123-12. Recalled by Pfizer Inc.. Units affected: 544400 packages.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on July 1, 2020. Severity: Low. Recall number: D-1342-2020.